Vivos (RDGL) Net Equity Issued and Repurchased (2010 - 2024)
Vivos (RDGL) reported Net Equity Issued and Repurchased of $709000.0 for Q2 2024, up 445.38% sequentially from $130000.0 in Q1 2024.
Vivos (RDGL) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Vivos (RDGL) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $709000.0 in Q2 2024.
- For the quarter ending Q2 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $709000.0; the trailing twelve-month figure through Sep 2024 stood at $1.4 million (up 991.62% YoY), and the FY2023 full-year result was $1.2 million, down 3.34% from the prior year.
- Net Equity Issued and Repurchased improved to $709000.0 in Q2 2024, from $130000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $709000.0 in Q2 2024 to a low of $125280.0 in Q1 2020.
- A 3-year average of $373215.0 and a median of $329290.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 150.56% in 2020, while the deepest fall reached 150.56% in 2020.
- Tracing RDGL's Net Equity Issued and Repurchased over 3 years: stood at $125280.0 in 2020, then soared by 321.92% to $528580.0 in 2023, then jumped by 34.13% to $709000.0 in 2024.
- Business Quant data shows RDGL's Net Equity Issued and Repurchased at $709000.0 in Q2 2024, $130000.0 in Q1 2024, and $528580.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 12.70 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | - |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 709,000.00 |
| Jun 30, 2024 | 709,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 528,580.00 |
| Dec 31, 2023 | 528,580.00 |
| Mar 31, 2020 | 125,280.00 |
| Mar 31, 2020 | 125,280.00 |
| Mar 31, 2019 | 50,000.00 |
| Mar 31, 2019 | 50,000.00 |
| Sep 30, 2010 | 500,000.00 |
| Sep 30, 2010 | 500,000.00 |